1. Home
  2. BCAB vs JUNE Comparison

BCAB vs JUNE Comparison

Compare BCAB & JUNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • JUNE
  • Stock Information
  • Founded
  • BCAB 2007
  • JUNE 1998
  • Country
  • BCAB United States
  • JUNE Hong Kong
  • Employees
  • BCAB N/A
  • JUNE N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • JUNE
  • Sector
  • BCAB Health Care
  • JUNE
  • Exchange
  • BCAB Nasdaq
  • JUNE Nasdaq
  • Market Cap
  • BCAB 91.4M
  • JUNE 59.6M
  • IPO Year
  • BCAB 2020
  • JUNE 2024
  • Fundamental
  • Price
  • BCAB $1.85
  • JUNE $5.20
  • Analyst Decision
  • BCAB Strong Buy
  • JUNE
  • Analyst Count
  • BCAB 2
  • JUNE 0
  • Target Price
  • BCAB $6.00
  • JUNE N/A
  • AVG Volume (30 Days)
  • BCAB 1.9M
  • JUNE 53.3K
  • Earning Date
  • BCAB 11-05-2024
  • JUNE 11-23-2024
  • Dividend Yield
  • BCAB N/A
  • JUNE N/A
  • EPS Growth
  • BCAB N/A
  • JUNE N/A
  • EPS
  • BCAB N/A
  • JUNE N/A
  • Revenue
  • BCAB N/A
  • JUNE $4,787,748.00
  • Revenue This Year
  • BCAB N/A
  • JUNE N/A
  • Revenue Next Year
  • BCAB N/A
  • JUNE N/A
  • P/E Ratio
  • BCAB N/A
  • JUNE N/A
  • Revenue Growth
  • BCAB N/A
  • JUNE N/A
  • 52 Week Low
  • BCAB $1.14
  • JUNE $3.60
  • 52 Week High
  • BCAB $4.02
  • JUNE $5.81
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 47.87
  • JUNE N/A
  • Support Level
  • BCAB $1.86
  • JUNE N/A
  • Resistance Level
  • BCAB $2.40
  • JUNE N/A
  • Average True Range (ATR)
  • BCAB 0.25
  • JUNE 0.00
  • MACD
  • BCAB -0.01
  • JUNE 0.00
  • Stochastic Oscillator
  • BCAB 30.38
  • JUNE 0.00

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About JUNE Junee Limited Ordinary Shares

Junee Ltd is a holding company that operates through its subsidiary. It is an interior design and fit-out service provider in Hong Kong. It provides design, fit-out and repair and maintenance services for commercial and residential buildings. The design service includes both the consultation with its staff and the actual design work and it provides a specific conceptualized design with layout plans, detailed design drawings, advice relating to, and other items to be used to produce a preliminary design plan and quotation for clients' considerations. Fit-out works include installing protective materials to cover floors or walls, installing or constructing partition walls, and other electrical and wiring works. Repair and maintenance works include, among other things.

Share on Social Networks: